212
Participants
Start Date
August 31, 2025
Primary Completion Date
July 31, 2027
Study Completion Date
July 31, 2028
Thrombin Generation Assay (TGA)
Hemostasis is a complex process in which genetic or environmental conditions can cause shifts either towards pro-thrombotic states resulting in thrombosis, or towards pro-hemorrhagic states resulting in uncontrolled bleeding. Tests to assess a more global hemostatic profile, such as the TGA, have appeared as a more reliable alternative to assess the real hemostatic capacity of an individual. TGA is a global dynamic assay simultaneously and continuously measuring thrombin generation. It monitors the cleavage of a fluorigenic substrate that is simultaneously compared to the known thrombin activity in a non-clotting plasma sample.
CHU de Grenoble, Grenoble
Chu St-Etienne, Saint-Etienne
Chu Clermont-Ferrand, Clermont-Ferrand
HCL, Lyon
Collaborators (2)
Diagnostica Stago
INDUSTRY
LEO Pharma
INDUSTRY
Ligue contre le cancer, France
OTHER
Centre Hospitalier Universitaire de Saint Etienne
OTHER